SCHEMBL2582352

SCHEMBL2582352

CC(=O)c1ccc(N2CCN(C(=O)c3noc4c3CN(C(=O)OC(C)(C)C)CC4)CC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.53
MAPT P10636 12/20 0.52
TP53 P04637 2/20 0.52
GPR119 Q8TDV5 1/20 0.50
KMT2A Q03164 2/20 0.49
THRB P10828 2/20 0.46
ALDH1A1 P00352 4/20 0.44
USP2 O75604 1/20 0.43
POLB P06746 1/20 0.43
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5533558 0.86 LMNA (0.51) LMNAMAPTTP53GPR119KMT2A
SCHEMBL3441391 0.81 KMT2A (0.57) LMNAMAPTTP53KMT2AALDH1A1
SCHEMBL22481977 0.81 USP2 (0.42) MAPTKMT2AALDH1A1USP2POLB
SCHEMBL1481563 0.77 GPR119 (0.78) LMNAMAPTGPR119KMT2AALDH1A1
SCHEMBL2588877 0.77 KMT2A (0.54) LMNAMAPTTP53KMT2ATHRB
SCHEMBL2576275 0.76 ADORA1 (0.46) MAPTTP53KMT2AALDH1A1USP2
Hydrochloric Acid SCHEMBL2585132 0.76 KMT2A (0.53) LMNAMAPTTP53KMT2ATHRB
SCHEMBL2585782 0.76 MAPT (0.48) LMNAMAPTTP53KMT2AALDH1A1
SCHEMBL16220615 0.75 ESR2 (0.45) LMNAMAPTALDH1A1USP2POLB
SCHEMBL22621730 0.73 HSP90AA1 (0.43) LMNAALDH1A1USP2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1869053-B1 SUBSTITUTED 4,5,6,7-TETRAHYDRO-ISOXAZOLO[4,5-C]PYRIDINE COMPOUNDS AND THEIR USE IN THE PRODUCTION OF MEDICAMENTS GRUENENTHAL GMBH (DE) 2013-10-09 EP disclosed
US-8048879-B2 Substituted 4,5,6,7-tetrahydro-isoxazolo[4,5-c]pyridine compounds and use thereof for producing medicaments GRUENENTHAL GMBH (DE) 2011-11-01 US disclosed
US-8048879-B2 Substituted 4,5,6,7-tetrahydro-isoxazolo[4,5-c]pyridine compounds and use thereof for producing medicaments GRUENENTHAL GMBH (DE) 2011-11-01 US disclosed
US-8048879-B2 Substituted 4,5,6,7-tetrahydro-isoxazolo[4,5-c]pyridine compounds and use thereof for producing medicaments GRUENENTHAL GMBH (DE) 2011-11-01 US disclosed
US-20090076001-A1 Substituted 4,5,6,7 -Tetrahydro-Isoxazolo[4,5-C]Pyridine Compounds and Use Thereof for Producing Medicaments GRUENENTHAL GMBH (DE) 2009-03-19 US disclosed
US-20090076001-A1 Substituted 4,5,6,7 -Tetrahydro-Isoxazolo[4,5-C]Pyridine Compounds and Use Thereof for Producing Medicaments GRUENENTHAL GMBH (DE) 2009-03-19 US disclosed
US-20090076001-A1 Substituted 4,5,6,7 -Tetrahydro-Isoxazolo[4,5-C]Pyridine Compounds and Use Thereof for Producing Medicaments GRUENENTHAL GMBH (DE) 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076001-A1 Substituted 4,5,6,7 -Tetrahydro-Isoxazolo[4,5-C]Pyridine Compounds and Use Thereof for Producing Medicaments P2RX5, P2RX4, P2RX7 LMNA 2302/4885MAPT 3693/4885TP53 3916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.